4 Host, 96T, apoptosis, array, Assay, Bacteria Pig Pigeon, Bafilomycin A1, Deoxycholic Acid Sodium Salt, Glycodeoxycholic Acid, GMO, Green, Pamabrom 100Mg, Pepstatin A, Phospho 4Ebp1, Plant, Plate, Tubastatin A, Valproic Acid Sodium Salt
Isotope fractionation (δ 13 C, δ 15 N) and microbial community response in degradation of petroleum hydrocarbons
This examine investigated the isotope results of δ13C and δ15N and microbial response throughout biodegradation of hydrocarbons by biostimulation with nitrate or compost within the petroleum-contaminated soil. Compost and KNO3 amendments promoted the whole petroleum hydrocarbon (TPH) elimination accompanied by a big enhance of Actinobacteria and Firmicutes phyla. Soil alpha range decreased after 90 days of biostimulation. An inverse vital carbon isotope impact (εc = 16.6 ± 0.8‰) and sturdy vital nitrogen isotope impact (εN = -24.20 ± 9.54‰) had been proven by the KNO3 supplementation.
For compost modification, vital carbon and nitrogen isotope impact had been εc = 38.8 ± 1.1‰ and εN = -79.49 ± 16.41‰, respectively. A transparent distinction of the carbon and nitrogen steady isotope fractionation was evident by KNO3 or compost modification, which indicated that the mechanisms of petroleum degradation by including compost or KNO3 could also be completely different.
Compound-specific carbon isotope evaluation of unstable natural compounds in complicated soil extracts utilizing purge and entice focus coupled to heart-cutting two-dimensional gasoline chromatography-isotope ratio mass spectrometry
Compound-specific carbon isotope evaluation (CSIA) is a strong instrument to trace the origin and destiny of natural subsurface contaminants together with petroleum and chlorinated hydrocarbons and is often utilized to water samples. Nonetheless, soil can kind a big contaminant reservoir. In soil samples, it may be difficult to get well adequate quantities of unstable natural compounds (VOC) to carry out CSIA. Soil samples usually include complicated contaminant mixtures and gasoline chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) is very depending on good chromatographic separation as a result of conversion to a single analyte.
To increase the applicability of CSIA to complicated unstable natural compound mixtures in soil samples, and to get well adequate quantities of goal compounds for carbon CSIA, we in contrast two soil extraction solvents, tetraglyme (TGDE) and methanol, and developed a heart-cutting two-dimensional GC-GC-C-IRMS technique. We used purge & entice focus of solvent-water mixtures to extend the quantity of analyte delivered to the column and thus decrease technique detection limits. We optimized purge & entice and chromatographic parameters for twelve goal compounds, together with one affected by poor purge effectivity.
Through the use of a 30 m thick-film non-polar column within the first and a 15 m polar column within the second dimension, we achieved good chromatographic separation for the goal compounds in troublesome matrices and excessive accuracy (trueness and precision) for carbon isotopic evaluation. Tetraglyme extraction was proven to supply benefits over methanol for purge & entice focus, resulting in decrease goal compound technique detection limits for CSIA of soil samples.
The applicability of the developed technique was demonstrated for a case examine on soil extracts from a former manufacturing facility. Our strategy extends the applicability of CSIA to an necessary matrix that always controls the long-term destiny of contaminants within the subsurface.
Growth of Secure Isotope Dilution Assays for the Evaluation of Pure Types of Vitamin B12 in Meat
The primary a number of steady isotope dilution assay technique was developed for the simultaneous willpower of 4 cobalamins, particularly, hydroxocobalamin (OHCbl), adenosylcobalamin (AdoCbl), methylcobalamin (MeCbl), and cyanocobalamin (CNCbl), of their native kinds. The pattern preparation was optimized with enzyme therapy and immunoaffinity purification.
The evaluation was carried out by LC-MS/MS utilizing respective 15N-labeled cobalamins as inside requirements. Methodology validation resulted in limits of detection starting from 0.19 to 0.58 ng/g and limits of quantification starting from 0.68 to 1.73 ng/g. Recoveries at three ranges had been between 82 and 121%. Intra-day and inter-day precisions had been beneath 6% and 11% RSD, respectively.
The evaluation of a reference materials resulted in a variance of <1% from the licensed worth. The newly developed technique demonstrated wonderful sensitivity, restoration, accuracy, and reproducibility and was additional utilized to quantitate the 4 cobalamins in varied meats.
Boron Isotope Evaluation Reveals Borate Selectivity in Seaweeds
The function of boron in terrestrial plant physiology is numerous and more and more nicely understood, however its function in marine aquatic eukaryotes is much less clear. Our analysis reveals a particular and huge offset in boron isotopes from seawater, no matter seaweed kind or season. We present that the offset is according to the incorporation of borate from seawater. Boron is a recognized micronutrient in vegetation however only a few research have used boron isotopes to research boron’s function in plant physiology.
Seaweed, as essentially the most primitive multicellular plant, has an necessary function in investigating wider plant diversifications that use boron to fulfill purposeful wants. Moreover, seaweed and different vegetation are a key base nutrient supplier in meals webs, supplying boron to customers and enjoying a essential function in boron environmental biking.
The Intermolecular NOE Will depend on Isotope Choice: Brief Vary vs Lengthy Vary Conduct
The nuclear Overhauser impact (NOE) is a strong instrument in molecular construction elucidation, combining the refined chemical shift of NMR and three-dimensional data impartial of chemical connectivity. Its utilization for intermolecular research, nevertheless, is essentially restricted by an unspecific long-ranged interplay habits.
This joint experimental and computational work reveals that correct collection of interacting isotopes can overcome these limitations: Isotopes with strongly differing gyromagnetic ratios give rise to short-ranged intermolecular NOEs. On this mild, current NOE experiments have to be re-evaluated and future ones might be designed accordingly. Thus, a brand new chapter on intermolecular construction elucidation is opened.
Comparability of isotope ratio mass spectrometry and cavity ring-down spectroscopy procedures and precision of the doubly labeled water technique in several physiological specimens
Rationale: This examine determines if saliva assortment procedures for the doubly labeled water (DLW) technique, used for measuring complete vitality expenditure (TEE), are akin to urine and plasma assortment. Each the cavity ring-down spectroscopy (CRDS) and isotope ratio mass spectrometry (IRMS) evaluation strategies are in contrast.
Strategies: Saliva specimens had been collected from contributors for the DLW technique. Specimens had been collected below completely different situations; after consumption of faucet water, after chewing gum, and through publicity to situations of excessive and low relative humidity. The isotopes in saliva had been in contrast with simultaneous plasma and urine assortment. TEE calculated from saliva and analyzed by CRDS was in comparison with that of plasma analyzed by IRMS.
Outcomes: The within-individual variances weren’t considerably completely different between the saliva specimens(0.4‰) and plasma(0.3‰). Following the oral dose of DLW, the saliva specimens displayed a shorter equilibration time to urine. When contributors consumed 500mL of faucet water, the enrichment of saliva specimens reached a brand new plateau worth sooner than urine. Saliva assortment uncovered to excessive ambient humidity situations was barely much less enriched as in comparison with low humidity situations whereas urine enrichment was unaffected.
In distinction, whereas the within-individual results of gum chewing throughout saliva assortment on 18 O had been unaffected, the abundance of 2 H in saliva was barely decrease after chewing the gum. The within-individual distinction between TEE calculated from saliva versus calculated from plasma analyzed by IRMS didn’t differ from zero, and the SD was not completely different from that predicted by a propagation of error evaluation based mostly on analytical error alone.
Conclusions: Our findings help utilizing saliva specimens for the DLW technique. Evaluation of plasma and urine, nevertheless, require lowering the reminiscence impact arising from contaminants. Additionally, it ought to be carried out in a fashion that minimizes publicity to air the place specimens could also be uncovered to evaporation or contamination from water vapor throughout sampling.
 AAV3-GFP Control Virus |
|||
| AAV-303 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 3. |
|||
 AAV4-GFP Control Virus |
|||
| AAV-304 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 4. |
|||
 AAV5-GFP Control Virus |
|||
| AAV-305 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 5. |
|||
 AAV6-GFP Control Virus |
|||
| AAV-306 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 6. |
|||
 AAV2 Null Control Virus |
|||
| AAV-352 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 2. |
|||
 AAV3 Null Control Virus |
|||
| AAV-353 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 3. |
|||
 AAV4 Null Control Virus |
|||
| AAV-354 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 4. |
|||
 AAV5 Null Control Virus |
|||
| AAV-355 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 5. |
|||
 AAV6 Null Control Virus |
|||
| AAV-356 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Null (empty) control virus of AAV serotype 6. |
|||
 AAV2-Cre Control Virus |
|||
| AAV-310 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 2. |
|||
 AAV3-Cre Control Virus |
|||
| AAV-313 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 3. |
|||
 AAV4-Cre Control Virus |
|||
| AAV-314 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 4. |
|||
 AAV5-Cre Control Virus |
|||
| AAV-315 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 5. |
|||
 AAV6-Cre Control Virus |
|||
| AAV-316 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 6. |
|||
 AAV2-Luc Control Virus |
|||
| AAV-320 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 2. |
|||
 AAV3-Luc Control Virus |
|||
| AAV-323 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 3. |
|||
 AAV4-Luc Control Virus |
|||
| AAV-324 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 4. |
|||
 AAV5-Luc Control Virus |
|||
| AAV-325 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 5. |
|||
 AAV6-Luc Control Virus |
|||
| AAV-326 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 6. |
|||
 AAV2-LacZ Control Virus |
|||
| AAV-342 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 2. |
|||
 AAV3-LacZ Control Virus |
|||
| AAV-343 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 3. |
|||
 AAV4-LacZ Control Virus |
|||
| AAV-344 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 4. |
|||
 AAV5-LacZ Control Virus |
|||
| AAV-345 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 5. |
|||
 AAV6-LacZ Control Virus |
|||
| AAV-346 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: LacZ control virus of AAV serotype 6. |
|||
) saCas9 Nuclease AAV Virus (AAV1) |
|||
| K208 | ABM | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml | EUR 375 |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
|||
 scAAV1-GFP Control Virus |
|||
| AAV-331 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 1. |
|||
 scAAV2-GFP Control Virus |
|||
| AAV-332 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 2. |
|||
 scAAV3-GFP Control Virus |
|||
| AAV-333 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 3. |
|||
 scAAV4-GFP Control Virus |
|||
| AAV-334 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 4. |
|||
 scAAV5-GFP Control Virus |
|||
| AAV-335 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 5. |
|||
 scAAV6-GFP Control Virus |
|||
| AAV-336 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 6. |
|||
 Lenti-III-UBC-GFP Control Virus |
|||
| LV027 | ABM | 4 x 500 ul | EUR 195 |
 Lenti-III-PGK-GFP Control Virus |
|||
| LV028 | ABM | 4 x 500 ul | EUR 195 |
 Lenti-III-EF1alpha-GFP Control Virus |
|||
| LV046 | ABM | 4 x 500 ul | EUR 195 |
) pCDH-Cuo-RFP-T2A-GFP (positive control virus) |
|||
| QM350VA-1 | SBI | >1 x 10^6 IFUs | EUR 573 |
 HSV-1 Virus Control Stock |
|||
| 20-4810020 | Quidel | Single Use, 400 µL, shipped frozen | Ask for price |
|
Description: Genetically Engineered BHK Cells |
|||
 HSV-2 Virus Control Stock |
|||
| 20-4820020 | Quidel | Single Use, 400 µL, shipped frozen | Ask for price |
|
Description: Genetically Engineered BHK Cells |
|||
 Zika Virus NS1 Control Antigen |
|||
| BA149R01 | Genovis AB | 1 mg | EUR 947 |
 Measles Virus IgG Control Serum |
|||
| C102G | Genovis AB | 3 mL | EUR 105 |
 Measles Virus IgM Control Serum |
|||
| C102M | Genovis AB | 3 mL | EUR 105 |
 Rubella Virus IgG Control Serum |
|||
| C129G | Genovis AB | 3 mL | EUR 105 |
 Rubella Virus IgM Control Serum |
|||
| C129M | Genovis AB | 3 mL | EUR 105 |
 Lenti-III-PGK-Luc Control Virus |
|||
| LV088 | ABM | 4 x 500 ul | EUR 195 |
 pRedTK-CMV Virus [positive control] |
|||
| SR10052VA-1 | SBI | >2 x 10^6 IFUs | EUR 625 |
 pRedZeo-CMV Virus [positive control] |
|||
| SR10046VA-1 | SBI | >2 x 10^6 IFUs | EUR 625 |
 pGreenZeo-CMV Virus [positive control] |
|||
| SR501VA-1 | SBI | >2 x 10^6 IFUs | EUR 608 |
 Zika Virus Human IgA Assay Control |
|||
| BC149A | Genovis AB | 1 mL | EUR 105 |
 Zika Virus Human IgG Assay Control |
|||
| BC149G | Genovis AB | 1 mL | EUR 105 |
 Zika Virus Human IgM Assay Control |
|||
| BC149M | Genovis AB | 1 mL | EUR 105 |
 pGreenZeo-mCMV Virus [negative control] |
|||
| SR500VA-1 | SBI | >2 x 10^6 IFUs | EUR 608 |
 Dengue Virus Human IgG Assay Control |
|||
| BC114G | Genovis AB | 1 mL | EUR 105 |
 Dengue Virus Human IgM Assay Control |
|||
| BC114M | Genovis AB | 1 mL | EUR 105 |
 Influenza A Virus IgA Control Serum |
|||
| C1231A | Genovis AB | 3 mL | EUR 105 |
 Influenza A Virus IgG Control Serum |
|||
| C1231G | Genovis AB | 3 mL | EUR 105 |
 Influenza A Virus IgM Control Serum |
|||
| C1231M | Genovis AB | 3 mL | EUR 105 |
 Influenza B Virus IgA Control Serum |
|||
| C1232A | Genovis AB | 3 mL | EUR 105 |
 Influenza B Virus IgG Control Serum |
|||
| C1232G | Genovis AB | 3 mL | EUR 105 |
 Influenza B Virus IgM Control Serum |
|||
| C1232M | Genovis AB | 3 mL | EUR 105 |
 Mumps Virus Nucleoprotein Control Antigen |
|||
| BA103R01 | Genovis AB | 1 mg | EUR 1016 |
 Measles Virus Nucleoprotein Control Antigen |
|||
| BA102R01 | Genovis AB | 1 mg | EUR 1016 |
 Mumps/Parotitis Virus IgG Control Serum |
|||
| C103G | Genovis AB | 3 mL | EUR 105 |
 Mumps/Parotitis Virus IgM Control Serum |
|||
| C103M | Genovis AB | 3 mL | EUR 105 |
 EZ‐Seneca Valley Virus A Control Set |
|||
| TC-9080-096 | Tetracore | each | EUR 90 |
 Chikungunya Virus Human IgG Assay Control |
|||
| BC148G | Genovis AB | 1 mL | EUR 105 |
 Chikungunya Virus Human IgM Assay Control |
|||
| BC148M | Genovis AB | 1 mL | EUR 105 |
 Varicella-Zoster Virus IgA Control Serum |
|||
| C104A | Genovis AB | 3 mL | EUR 105 |
 Varicella-Zoster Virus IgG Control Serum |
|||
| C104G | Genovis AB | 3 mL | EUR 105 |
 Varicella-Zoster Virus IgM Control Serum |
|||
| C104M | Genovis AB | 3 mL | EUR 105 |
 mouse monoclonal antibody, clone ADK1a, Purified) Adeno-Associated Virus 1 / AAV1 (intact particle) mouse monoclonal antibody, clone ADK1a, Purified |
|||
| BM5093 | Origene Technologies GmbH | 50 µg | Ask for price |
 West Nile Virus Human IgG Assay Control |
|||
| BC141G | Genovis AB | 1 mL | EUR 105 |
 West Nile Virus Human IgM Assay Control |
|||
| BC141M | Genovis AB | 1 mL | EUR 105 |
 isotype control) Virus-Like Particles (VLPs) isotype control |
|||
| CSB-MP3838 | Cusabio | 11453 mg | Ask for price |
 Parainfluenza Virus Human IgA Assay Control |
|||
| BC126A | Genovis AB | 1 mL | EUR 105 |
 Parainfluenza Virus Human IgG Assay Control |
|||
| BC126G | Genovis AB | 1 mL | EUR 105 |
 Herpes Simplex Virus 1 IgM Control Serum |
|||
| C1051M | Genovis AB | 3 mL | EUR 105 |
 Herpes Simples Virus 2 IgM Control Serum |
|||
| C1052M | Genovis AB | 3 mL | EUR 105 |
 Epstein-Barr Virus EA IgG Control Serum |
|||
| C1363G | Genovis AB | 3 mL | EUR 105 |
 Respiratory Syncytial Virus IgA Control Serum |
|||
| C113A | Genovis AB | 3 mL | EUR 105 |
 Respiratory Syncytial Virus IgG Control Serum |
|||
| C113G | Genovis AB | 3 mL | EUR 105 |
 Epstein-Barr Virus VCA IgG Control Serum |
|||
| C1361G | Genovis AB | 3 mL | EUR 105 |
 Epstein-Barr Virus VCA IgM Control Serum |
|||
| C1361M | Genovis AB | 3 mL | EUR 105 |
 Dengue Virus superior Human IgM Assay Control |
|||
| BC1141M | Genovis AB | 1 mL | EUR 105 |
 Influenza A virus HA Control/blocking peptide |
|||
| AB-23091-P | Alpha Diagnostics | 100ug | EUR 196.8 |
 Herpes Simplex Virus 1 gP IgG Control Serum |
|||
| C1051G | Genovis AB | 3 mL | EUR 105 |
 Herpes Simplex Virus 2 gP IgG Control Serum |
|||
| C1052G | Genovis AB | 3 mL | EUR 105 |
 Herpes Simplex Virus 1+2 IgA Control Serum |
|||
| C105A | Genovis AB | 3 mL | EUR 105 |
 Herpes Simplex Virus 1+2 IgG Control Serum |
|||
| C105G | Genovis AB | 3 mL | EUR 105 |
 Herpes Simplex Virus 1+2 IgM Control Serum |
|||
| C105M | Genovis AB | 3 mL | EUR 105 |
 mouse monoclonal antibody, clone ADK1a, Biotin, Purified) Adeno-Associated Virus 1 / AAV1 (intact particle) mouse monoclonal antibody, clone ADK1a, Biotin, Purified |
|||
| BM5093B | Origene Technologies GmbH | 750 µl | Ask for price |
 Protein Isotype Control) Virus-Like Particle (VLP) Protein Isotype Control |
|||
| VLP-N5213 | ACROBIOSYSTEMS | 30ug | EUR 428 |
|
Description: VLP isotype control (VLP-N5213) is expressed from human 293 cells (HEK293). |
|||
 Tick-Borne Encephalitis Virus IgG Control Serum |
|||
| C112G | Genovis AB | 3 mL | EUR 105 |
 Tick-Borne Encephalitis Virus IgM Control Serum |
|||
| C112M | Genovis AB | 3 mL | EUR 105 |
 Epstein-Barr Virus EBNA-1 IgG Control Serum |
|||
| C1362G | Genovis AB | 3 mL | EUR 105 |
) Vaccinia virus Complement control protein C3 (VACWR025) |
|||
| 1-CSB-YP302389VAI | Cusabio |
|
|
|
Description: Recombinant Vaccinia virus Complement control protein C3(VACWR025) expressed in Yeast |
|||
) pGreenFire 2.0-CMV positive control virus (pGF2-CMV-rFluc-T2A-GFP-mPGK-Puro) |
|||
| TR410VA-P | SBI | >2 x 10^6 IFUs | EUR 632 |
 AAV1 SaCas9 |
|||
| 78479 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_Cas9 is an endonuclease enzyme that introduces a double stranded break into the DNA when recruited to a specific DNA sequence by the sgRNA (single guide RNA). This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the gene._x000D_SaCas9 (Staphylococcus aureus CRISPR-associated protein 9) has demonstrated high cutting efficiency in mammalian cells, and its smaller size makes it ideal for packaging into AAV. SaCas9 recognizes a longer protospacer adjacent motif (PAM) site, 5'-NNGRRT-3', than the more traditional SpCas9 (Streptococcus pyogenes CRISPR-associated protein 9). These AAV particles constitutively express SaCas9 under the control of a CMV promoter. |
|||
) pGreenPuro Scramble Hairpin Control - Virus (for shRNAs and miRZips) |
|||
| MZIP000-VA-1 | SBI | >1 x 10^6 IFUs | EUR 652 |
 AAV1 ZsGreen |
|||
| 78443 | BPS Bioscience | 50 µl x 2 | EUR 545 |
|
Description: Adeno-Associated Virus Serotype 1 (AAV1) exhibits high homology with other AAV serotypes. AAV1 efficiently transduces muscle tissue, as determined by a region of the capsid protein VP1 (amino acids 350 to 430) which functions as a major determinant of tissue tropism._x000D_These AAV1 particles constitutively express ZsGreen under a CMV promoter. ZsGreen is a human codon-optimized variant of the green fluorescent protein isolated from reef coral (Zoanthus sp). It has been engineered for higher expression in mammalian cells and is up to four times brighter than enhanced GFP (eGFP). ZsGreen expression and AAV1 transduction efficiency can easily be verified and optimized by fluorescence microscopy or flow cytometry. ZsGreen has an excitation wavelength of 493 nm and an emission wavelength of 505 nm. |
|||
 AAV1 antibody |
|||
| 10R-2473 | Fitzgerald | 5 mL | EUR 550.8 |
|
Description: Mouse monoclonal AAV1 antibody |
|||
